Clinical Trials List
2025-02-03 - 2029-12-23
Recruiting6
ICD-10C22.0
Liver cell carcinoma
ICD-10C22.2
Hepatoblastoma
ICD-10C22.3
Angiosarcoma of liver
ICD-10C22.4
Other sarcomas of liver
ICD-10C22.7
Other specified carcinomas of liver
ICD-10C22.8
Malignant neoplasm of liver, primary, unspecified as to type
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.0
Malignant neoplasm of liver, primary
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林伯庭 無
- Wei-Chen Lee 無
- 呂嘉偉 無
- 鄭志軒 無
- Kun-Ming Chan 無
- 周宏學 無
- 李勁樵 無
- 李兆偉 無
- 洪豪謙 無
- Yi-Chung Hsieh 無
- 吳庭榕 無
- 王瑜肇 無
- 吳宗翰 無
- Chia-Hsun Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭明濬 無
- 黃詩喻 無
- Tai-Jan Chiu 無
- Yu-Li Su 無
- Shau-Hsuan Li 無
- 陳彥豪 無
- 林昶廷 無
- 劉建廷 無
- 曾亮節 無
- 吳佳哲 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱彥程 無
- Chih-Chieh Yen 無
- Yih-Jyh Lin 無
- 劉奕廷 無
- Chiu Hung Chiu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
740 participants
